Although a similar pattern of survival curves was observed in DDFS and OS for non-IBC group, the survival analysis with optimal grouping for ER% and PR% identified in the training set showed no significant differences in prognosis in the IBC group (Supplementary Fig. 3a-d). This evidence concerns the gene PGR and inflammatory breast carcinoma.